Thermo Fisher Scientific Inc.
TMO· NYSE
TMOThermo Fisher Scientific Inc.
Filed Feb 23, 2023 · 10-K · 54 days after period end · 0000097745-23-000008
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019 |
|---|---|---|---|---|
| Revenue | $11.45B | $10.70B | $10.55B | $6.83B |
| Net Income | $1.57B | $1.66B | — | — |
| EPS Diluted | — | — | — |
Thermo Fisher Scientific Inc. · CIK 97745 · Engraved from SEC EDGAR
| $2.49 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2022 · filed Feb 23, 2023 · 54 d after period end
